Public health impact of adverse bone effects of oral corticosteroids.

Public health impact of adverse bone effects of oral corticosteroids.

AIMS: The objective of this study was to estimate the number of fractures attributed to oral corticosteroid use. METHODS: Information was obtained from the General Practice Research Database which contains medical records of general practitioners in the UK. The total number of corticosteroid-relate...

Descrizione completa

Dettagli Bibliografici
Autori principali:	van Staa, T, Abenhaim, L, Cooper, C, Zhang, B, Leufkens, H
Natura:	Journal article
Lingua:	English
Pubblicazione:	2001

Documenti analoghi

Use of oral corticosteroids and risk of fractures.
di: Van Staa, T, et al.
Pubblicazione: (2000)

Use of oral corticosteroids and risk of fractures. June, 2000.
di: Van Staa, T, et al.
Pubblicazione: (2005)

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.
di: van Staa, T, et al.
Pubblicazione: (2000)

The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results.
di: Van Staa, T, et al.
Pubblicazione: (2000)

Use of oral corticosteroids and risk of fractures (reprinted from JBMR, vol. 15, pg. 993-1000, yr. 2000)
di: Van Staa, T, et al.
Pubblicazione: (2005)

Children and the risk of fractures caused by oral corticosteroids.
di: van Staa, T, et al.
Pubblicazione: (2003)

Inhaled corticosteroids and risk of fractures
di: Van Staa, T, et al.
Pubblicazione: (2000)

Use of inhaled corticosteroids and risk of fractures.
di: van Staa, T, et al.
Pubblicazione: (2001)

Inhaled corticosteroids and hip fracture: disease or drugs?
di: van Staa, T, et al.
Pubblicazione: (2003)

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.
di: van Staa, T, et al.
Pubblicazione: (2002)

Upper gastrointestinal adverse events and cyclical etidronate.
di: van Staa, T, et al.
Pubblicazione: (1997)

Are inhaled corticosteroids associated with an increased risk of fracture in children?
di: van Staa, T, et al.
Pubblicazione: (2004)

The use of inhaled corticosteroids is not associated with an increased risk of fracture in children.
di: van Staa, T, et al.
Pubblicazione: (2001)

Bone loss and inhaled glucocorticoids.
di: van Staa, T, et al.
Pubblicazione: (2002)

Inhaled corticosteroids and hip fracture: Disease or drugs? [2] (multiple letters)
di: Van Staa, T, et al.
Pubblicazione: (2003)

Use of cyclical etidronate and prevention of non-vertebral fractures.
di: van Staa, T, et al.
Pubblicazione: (1998)

Re: Use of cyclic etidronate and the prevention of non-vertebral fractures - Reply
di: van Staa, T, et al.
Pubblicazione: (1998)

Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
di: van Staa, T, et al.
Pubblicazione: (2007)

Paget's disease of the bone in general clinical practice.
di: van Staa, T, et al.
Pubblicazione: (2000)

CUMULATIVE RISKS OF FRACTURE IN PATIENTS USING ORAL GLUCOCORTICOIDS
di: Van Staa, T, et al.
Pubblicazione: (2004)

Incidence and natural history of Paget's disease of bone in England and Wales.
di: van Staa, T, et al.
Pubblicazione: (2002)

Diseases and drugs associated with osteoporosis predict fractures at different sites
di: van Staa, T, et al.
Pubblicazione: (2001)

Does a fracture at one site predict later fractures at any other site?
di: van Staa, T, et al.
Pubblicazione: (2001)

Does a fracture at one site predict later fractures at other sites? A British cohort study.
di: van Staa, T, et al.
Pubblicazione: (2002)

The estimation of cost-effectiveness thresholds prior to the start of large clinical studies
di: Van Staa, T, et al.
Pubblicazione: (2006)

Use of nonsteroidal anti-inflammatory drugs and risk of fractures.
di: van Staa, T, et al.
Pubblicazione: (2000)

Is persistence to bisphosphonate therapy related only to dosing regimen?
di: van Staa, T, et al.
Pubblicazione: (2006)

Utility of medical and drug history in fracture risk prediction among men and women.
di: van Staa, T, et al.
Pubblicazione: (2002)

Fracture risk with intermittent high-dose oral glucocorticoid therapy.
di: De Vries, F, et al.
Pubblicazione: (2007)

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids.
di: van Staa, T, et al.
Pubblicazione: (2005)

Risk of Fracture and Bone Mineral Density in Stroke Response
di: Pouwels, S, et al.
Pubblicazione: (2010)

A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD
di: Tse G, et al.
Pubblicazione: (2023-11-01)

Epidemiology of fractures in England and Wales.
di: van Staa, T, et al.
Pubblicazione: (2001)

The epidemiology of fractures in England and Wales
di: van Staa, T, et al.
Pubblicazione: (2001)

Individualizing the risks and benefits of postmenopausal hormone therapy.
di: van Staa, T, et al.
Pubblicazione: (2008)

Adverse Effects of Long-Term Oral Corticosteroids in the Department of Dermatology, Antananarivo, Madagascar
di: Sendrasoa FA, et al.
Pubblicazione: (2021-09-01)

Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
di: de Vries, F, et al.
Pubblicazione: (2007)

THE IMPACT OF SYSTEMIC CORTICOSTEROID THERAPY ON ORAL HEALTH: COMPLICATIONS AND MANAGEMENT STRATEGIES
di: Mihaela Paula Toader, et al.
Pubblicazione: (2023-11-01)

Risk of adverse events in patients with bullous pemphigoid treated with oral corticosteroids in the United States
di: Jonathan I. Silverberg, et al.
Pubblicazione: (2024-09-01)

Adverse effects of topical corticosteroids in pregnancy revisited
di: Chi, C, et al.
Pubblicazione: (2008)